Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma
Open Access
- 27 July 2020
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 12 (15) , 15359-15373
Abstract
Background: Papillary renal cell carcinoma (pRCC) was the 2nd most common subtype, accounting for approximately 15% incidence of renal cell carcinoma (RCC). Immune related long non-coding RNAs (IR-lncRs) plentiful in immune cells and immune microenvironment (IME) are potential in evaluating prognosis and assessing the effects of immunotherapy. A completed and meaningful IR-lncRs analysis based on abundant pRCC gene samples from The Cancer Genome Atlas (TCGA) will provide insight in this field.Keywords
This publication has 28 references indexed in Scilit:
- Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016”European Urology Focus, 2019
- Urinary Bladder Pathology: World Health Organization Classification and American Joint Committee on Cancer Staging UpdateArchives of Pathology & Laboratory Medicine, 2018
- MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinomaInternational Urology and Nephrology, 2018
- SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastizationEpigenetics, 2017
- Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell CancerJournal of Clinical Oncology, 2017
- Immunomonitoring Reveals Interruption of Anergy After Vaccination in a Case of Type-2-Papillary Renal Cell CarcinomaImmunotherapy, 2017
- Long-term Response to Nivolumab and Acute Renal Failure in a Patient with Metastatic Papillary Renal Cell Carcinoma and a PD-L1 Tumor Expression Increased with Sunitinib Therapy: A Case ReportFrontiers in Oncology, 2016
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder TumoursEuropean Urology, 2016
- Papillary renal cell carcinoma: A review of the current therapeutic landscapeCritical Reviews in Oncology/Hematology, 2015
- PD-L1 expression in nonclear-cell renal cell carcinomaAnnals of Oncology, 2014